Showing results (2601-2610 of 4,203) with videos related to
Sort By:
Pageof 421
Current Topics in Medicinal Chemistry|October 12, 2013
Fluorinated compounds against Mycobacterium tuberculosisNúbia Boechat, Mônica M BastosCurrent Topics in Medicinal Chemistry|October 12, 2013
Targeting the histidine pathway in Mycobacterium tuberculosisJuleane Lunardi, José Eduardo S Nunes, Cristiano V Bizarro, et al.Current Topics in Medicinal Chemistry|April 10, 2009
Inhibition of histone deacetylases: a pharmacological approach to the treatment of non-cancer disordersNorbert L Wiech, Jed F Fisher, Paul Helquist, et al.Current Topics in Medicinal Chemistry|April 10, 2009
Non-cancer uses of histone deacetylase inhibitors: effects on infectious diseases and beta-hemoglobinopathiesDante Rotili, Giovanna Simonetti, Andrea Savarino, et al.Current Topics in Medicinal Chemistry|April 10, 2009
Targeting histone deacetylase inhibitors for anti-malarial therapyKatherine T Andrews, Thanh N Tran, Nicole C Wheatley, et al.Current Topics in Medicinal Chemistry|April 8, 2010
Adenosine receptor ligands in clinical trialsFlavio Rizzolio, Raffaele La Montagna, Tiziano Tuccinardi, et al.Current Topics in Medicinal Chemistry|April 8, 2010
Adenosine receptor modeling: what does the A2A crystal structure tell us?Diego Dal Ben, Catia Lambertucci, Gabriella Marucci, et al.Current Topics in Medicinal Chemistry|April 8, 2010
A3 receptor ligands: past, present and future trendsSabrina Taliani, Isabella Pugliesi, Marusca Bellandi, et al.Current Topics in Medicinal Chemistry|April 8, 2010
Discovery and development of endocannabinoid-hydrolyzing enzyme inhibitorsAnna Minkkilä, Susanna Saario, Tapio NevalainenCurrent Topics in Medicinal Chemistry|April 8, 2010
Targeting the endocannabinoid system for the treatment of cancer--a practical viewChristopher J Fowler, Sofia B Gustafsson, Sui Chu Chung, et al.Pageof 421